Estradiol Patent Expiration

Estradiol was first introduced by Novartis Pharmaceuticals Corp in its drug Estraderm on Sep 10, 1986. Other drugs containing Estradiol are Alora, Climara, Estrogel, Vagifem, Estradiol, Elestrin, Menostar, Estring, Fempatch, Divigel, Evamist, Minivelle, Imvexxy, Esclim, Vivelle, Vivelle-Dot. 39 different companies have introduced drugs containing Estradiol.


Estradiol Patents

Given below is the list of patents protecting Estradiol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Imvexxy US11266661 Vaginal inserted estradiol pharmaceutical compositions and methods Feb 02, 2034 Mayne Pharma
Imvexxy US10258630 Vaginal inserted estradiol pharmaceutical compositions and methods Dec 20, 2033 Mayne Pharma
Imvexxy US10398708 Vaginal inserted estradiol pharmaceutical compositions and methods Dec 20, 2033 Mayne Pharma
Imvexxy US9180091 Soluble estradiol capsule for vaginal insertion Dec 20, 2033 Mayne Pharma
Imvexxy US10471072 Vaginal inserted estradiol pharmaceutical compositions and methods Jun 18, 2033 Mayne Pharma
Imvexxy US10568891 Vaginal inserted estradiol pharmaceutical compositions and methods Jun 18, 2033 Mayne Pharma
Imvexxy US10668082 Vaginal inserted estradiol pharmaceutical compositions and methods Jun 18, 2033 Mayne Pharma
Imvexxy US10888516 Soluble estradiol capsule for vaginal insertion Jun 18, 2033 Mayne Pharma
Imvexxy US11065197 Soluble estradiol capsule for vaginal insertion Jun 18, 2033 Mayne Pharma
Imvexxy US11116717 Soluble estradiol capsule for vaginal insertion Jun 18, 2033 Mayne Pharma
Imvexxy US11123283 Soluble estradiol capsule for vaginal insertion Jun 18, 2033 Mayne Pharma
Imvexxy US10537581 Vaginal inserted estradiol pharmaceutical compositions and methods Nov 21, 2032 Mayne Pharma
Imvexxy US10806697 Vaginal inserted estradiol pharmaceutical compositions and methods Nov 21, 2032 Mayne Pharma
Imvexxy US10835487 Vaginal inserted estradiol pharmaceutical compositions and methods Nov 21, 2032 Mayne Pharma
Imvexxy US11241445 Vaginal inserted estradiol pharmaceutical compositions and methods Nov 21, 2032 Mayne Pharma
Imvexxy US11246875 Vaginal inserted estradiol pharmaceutical compositions and methods Nov 21, 2032 Mayne Pharma
Imvexxy US11304959 Vaginal inserted estradiol pharmaceutical compositions and methods Nov 21, 2032 Mayne Pharma
Imvexxy US11351182 Vaginal inserted estradiol pharmaceutical compositions and methods Nov 21, 2032 Mayne Pharma
Imvexxy US11497709 Vaginal inserted estradiol pharmaceutical compositions and methods Nov 21, 2032 Mayne Pharma
Imvexxy US9289382 Vaginal inserted estradiol pharmaceutical compositions and methods Nov 21, 2032 Mayne Pharma
Minivelle US8231906 Transdermal estrogen device and delivery Jul 04, 2030 Noven
Minivelle US9724310 Transdermal estrogen device and delivery Jul 10, 2028 Noven
Minivelle US9730900 Transdermal estrogen device and delivery Jul 10, 2028 Noven
Minivelle US9833419 Transdermal estrogen device and delivery Jul 10, 2028 Noven
Vagifem US7018992 Hormone composition Sep 17, 2022

(Expired)

Novo Nordisk Inc
Elestrin US7198801 Formulations for transdermal or transmucosal application Jun 25, 2022

(Expired)

Mylan Speciality Lp
Evamist US6978945 Dispensing device Nov 30, 2021

(Expired)

Padagis Us
Elestrin US7470433 Formulations for transdermal or transmucosal application Aug 03, 2021

(Expired)

Mylan Speciality Lp
Minivelle US6841716 Patch Apr 27, 2020

(Expired)

Noven
Menostar US5891868 Methods for treating postmenopausal women using ultra-low doses of estrogen Nov 21, 2017

(Expired)

Bayer Hlthcare
Menostar US6692763 Methods for treating postmenopausal women using ultra-low doses of estrogen Nov 21, 2017

(Expired)

Bayer Hlthcare
Vagifem US5860946 Instrument for inserting a suppository Jul 01, 2017

(Expired)

Novo Nordisk Inc
Evamist US6299900 Dermal penetration enhancers and drug delivery systems involving same Feb 19, 2017

(Expired)

Padagis Us
Evamist US6818226 Dermal penetration enhancers and drug delivery systems involving same Feb 19, 2017

(Expired)

Padagis Us
Evamist US6923983 Transdermal delivery of hormones Feb 19, 2017

(Expired)

Padagis Us
Minivelle US5646286 Palladium catalyzed vinylic substitution reactions with 2-substituted-pyridines Aug 12, 2014

(Expired)

Noven
Minivelle US5656286 Solubility parameter based drug delivery system and method for altering drug saturation concentration Aug 12, 2014

(Expired)

Noven
Vivelle-dot US5656286 Solubility parameter based drug delivery system and method for altering drug saturation concentration Aug 12, 2014

(Expired)

Sandoz
Minivelle US6024976 Solubility parameter based drug delivery system and method for altering drug saturation concentration Jan 07, 2014

(Expired)

Noven
Vivelle-dot US6024976 Solubility parameter based drug delivery system and method for altering drug saturation concentration Jan 07, 2014

(Expired)

Sandoz
Vivelle-dot US5474783 Solubility parameter based drug delivery system and method for altering drug saturation concentration Dec 12, 2012

(Expired)

Sandoz
Vivelle-dot US5958446 Solubility parameter based drug delivery system and method for altering drug saturation concentration Dec 12, 2012

(Expired)

Sandoz



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Estradiol's patents.

Given below is the list recent legal activities going on the following patents of Estradiol.

Activity Date Patent Number
Patent litigations
Patent Issue Date Used in PTA Calculation 28 Mar, 2006 US7018992
Recordation of Patent Grant Mailed 28 Mar, 2006 US7018992
Issue Notification Mailed 08 Mar, 2006 US7018992
Receipt into Pubs 23 Feb, 2006 US7018992
Dispatch to FDC 22 Feb, 2006 US7018992
Application Is Considered Ready for Issue 22 Feb, 2006 US7018992
Receipt into Pubs 20 Jan, 2006 US7018992
Printer Rush- No mailing 27 Sep, 2005 US7018992
Pubs Case Remand to TC 06 Sep, 2005 US7018992
Workflow - File Sent to Contractor 03 Jun, 2005 US7018992


Estradiol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Estradiol Generic API Manufacturers

Several generic applications have been filed for Estradiol. The first generic version for Estradiol was by Bristol Myers Squibb Co Pharmaceutical Research Institute and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Aug 2, 2024.

Given below is the list of companies who have filed for Estradiol generic, along with the locations of their manufacturing plants worldwide..


1. ALLERGAN

Allergan Sales Llc has filed for 1 generic for Estradiol. This 0.01% version comes by the name ESTRACE. Given below are the details of the strengths of this generic introduced by Allergan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01%

(reference standard)

(reference listed drug)

cream Prescription VAGINAL AB Jan 31, 1984


Manufacturing Plant Locations
New

Allergan's manufacturing plants are situated in 4 countries - United States, Costa Rica, France, Ireland. Given below are the details of these plant locations as well as the firm names of Allergan as present at those locations.

Country City Firm Name
United States
Cincinnati Allergan Sales LLC
Irvine Allergan Sales, LLC
Goleta Allergan
Campbell Allergan Sales, LLC dba Bioscience Laboratories
Madison ALLERGAN SALES, LLC
Waco Allergan Sales, LLC
Costa Rica
Heredia ALLERGAN
France
Pringy Allergan Industrie SAS
Ireland
Westport Allergan Pharmaceuticals Ireland




2. ALVOGEN

Alvogen Inc has filed for 1 generic for Estradiol. Given below are the details of the strengths of this generic introduced by Alvogen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01% cream Prescription VAGINAL AB Mar 5, 2018


Manufacturing Plant Locations
New

Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.

Country City Firm Name
United States
Morristown Alvogen, Inc




3. AMNEAL

Amneal Pharmaceuticals Llc has filed for 10 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/24HR film, extended release Prescription TRANSDERMAL AB3 Sep 28, 2020
0.075MG/24HR film, extended release Prescription TRANSDERMAL AB3 Sep 28, 2020
0.1MG/24HR film, extended release Prescription TRANSDERMAL AB3 Sep 28, 2020
0.0375MG/24HR film, extended release Prescription TRANSDERMAL AB3 Sep 28, 2020
0.025MG/24HR film, extended release Prescription TRANSDERMAL AB3 Sep 28, 2020
0.1% (1.25GM/PACKET) gel Prescription TRANSDERMAL AB Jul 12, 2024
0.1% (1GM/PACKET) gel Prescription TRANSDERMAL AB Jul 12, 2024
0.1% (0.75GM/PACKET) gel Prescription TRANSDERMAL AB Jul 12, 2024
0.1% (0.5GM/PACKET) gel Prescription TRANSDERMAL AB Jul 12, 2024
0.1% (0.25GM/PACKET) gel Prescription TRANSDERMAL AB Jul 12, 2024


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
East Hanover Amneal Pharmaceuticals LLC
Bridgewater Amneal Complex Products Research LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
Piscataway Amneal Pharmaceuticals, LLC
Paterson Amneal Pharmaceuticals, Llc
Glasgow Amneal Pharmaceuticals LLC
Branchburg Amneal Pharmaceuticals, LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
India
Hyderabad Amneal Oncology Private Limited
Matoda Amneal Pharmaceuticals Private Ltd.
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.




4. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 1 generic for Estradiol. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MCG tablet Prescription VAGINAL AB May 29, 2015






5. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 1 generic for Estradiol. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MCG tablet Prescription VAGINAL AB Aug 2, 2024


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc




6. BARR LABS INC

Barr Laboratories Inc has filed for 3 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG tablet Prescription ORAL AB Oct 22, 1997
1MG tablet Prescription ORAL AB Oct 22, 1997
2MG

(reference standard)

tablet Prescription ORAL AB Oct 22, 1997






7. BRISTOL MYERS SQUIBB

Bristol Myers Squibb Co has filed for 3 different strengths of generic version for Estradiol. All of these versions come by the name ESTRACE. Given below are the details of the strengths of this generic introduced by Bristol Myers Squibb.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG

(reference listed drug)

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
2MG

(reference listed drug)

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.5MG tablet Discontinued ORAL N/A Jun 30, 1993


Manufacturing Plant Locations
New

Bristol Myers Squibb's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bristol Myers Squibb as present at those locations.

Country City Firm Name
United States
Catano Bristol Myers Squibb Pr
Plainsboro Bristol Myers Squibb Company
Princeton Bristol Myers Squibb
Mayaguez Bristol Myers Squibb Caribbean Company




8. CHEMO RESEARCH SL

Chemo Research Sl has filed for 3 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Chemo Research Sl.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% (1GM/PACKET) gel Prescription TRANSDERMAL AB Aug 10, 2022
0.1% (0.5GM/PACKET) gel Prescription TRANSDERMAL AB Aug 10, 2022
0.1% (0.25GM/PACKET) gel Prescription TRANSDERMAL AB Aug 10, 2022






9. DR REDDYS LABS SA

Dr Reddys Laboratories Sa has filed for 3 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG tablet Discontinued ORAL N/A Mar 14, 1996
1MG tablet Discontinued ORAL N/A Mar 14, 1996
2MG tablet Discontinued ORAL N/A Mar 14, 1996






10. DURAMED PHARMS BARR

Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc has filed for 4 different strengths of generic version for Estradiol. All of these versions come by the name GYNODIOL. Given below are the details of the strengths of this generic introduced by Duramed Pharms Barr.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG tablet Discontinued ORAL N/A Dec 29, 1997
1MG tablet Discontinued ORAL N/A Dec 29, 1997
1.5MG tablet Discontinued ORAL N/A Dec 29, 1997
2MG tablet Discontinued ORAL N/A Dec 29, 1997






11. EPIC PHARMA LLC

Epic Pharma Llc has filed for 3 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG tablet Prescription ORAL AB Dec 29, 1998
0.5MG tablet Prescription ORAL AB Dec 29, 1998
2MG tablet Prescription ORAL AB Dec 29, 1998






12. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 1 generic for Estradiol. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MCG tablet Prescription VAGINAL AB Sep 14, 2018






13. LANNETT CO INC

Lannett Co Inc has filed for 3 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG tablet Discontinued ORAL N/A Jan 30, 1998
0.5MG tablet Discontinued ORAL N/A Jan 30, 1998
2MG tablet Discontinued ORAL N/A Jan 30, 1998






14. MYLAN

Mylan Pharmaceuticals Inc has filed for 1 generic for Estradiol. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01% cream Prescription VAGINAL AB Dec 29, 2017


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
San Carlos Mylan Pharmaceuticals Inc.
Saint Albans Mylan Technologies, Inc.
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
Morgantown Mylan Specialty, L.P.
Rockford Mylan Institutional, Inc.
Greensboro Mylan Pharmaceuticals Inc
India
Sinnar Mylan Laboratories Limited
Anekal Taluk, Bangalore Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Hyderabad Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta




15. MYLAN TECHNOLOGIES

Mylan Technologies Inc has filed for 6 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Mylan Technologies.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/24HR film, extended release Prescription TRANSDERMAL AB3 Aug 15, 2018
0.1MG/24HR film, extended release Prescription TRANSDERMAL AB3 Aug 15, 2018
0.075MG/24HR film, extended release Prescription TRANSDERMAL AB3 Aug 15, 2018
0.025MG/24HR film, extended release Prescription TRANSDERMAL AB3 Aug 15, 2018
0.0375MG/24HR film, extended release Prescription TRANSDERMAL AB3 Aug 15, 2018
0.06MG/24HR film, extended release Prescription TRANSDERMAL AB Jul 20, 2006


Manufacturing Plant Locations
New

Mylan Technologies's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Mylan Technologies as present at those locations.

Country City Firm Name
United States
Saint Albans Mylan Technologies, Inc.




16. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 3 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG tablet Discontinued ORAL N/A Apr 21, 1999
2MG tablet Discontinued ORAL N/A Apr 21, 1999
0.5MG tablet Discontinued ORAL N/A Apr 21, 1999






17. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 8 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% (1.25GM/PACKET) gel Prescription TRANSDERMAL AB Aug 24, 2023
0.1% (1GM/PACKET) gel Prescription TRANSDERMAL AB Aug 24, 2023
0.1% (0.75GM/PACKET) gel Prescription TRANSDERMAL AB Aug 24, 2023
0.1% (0.5GM/PACKET) gel Prescription TRANSDERMAL AB Aug 24, 2023
0.1% (0.25GM/PACKET) gel Prescription TRANSDERMAL AB Aug 24, 2023
2MG tablet Prescription ORAL AB Sep 6, 2023
0.5MG tablet Prescription ORAL AB Sep 6, 2023
1MG tablet Prescription ORAL AB Sep 6, 2023


Manufacturing Plant Locations
New

Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.

Country City Firm Name
United States
East Windsor Novitium Pharma LLC




18. NOVO NORDISK INC

Novo Nordisk Inc has filed for 3 different strengths of generic version for Estradiol. All of these versions come by the name INNOFEM. Given below are the details of the strengths of this generic introduced by Novo Nordisk Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG tablet Discontinued ORAL N/A Nov 19, 1999
2MG tablet Discontinued ORAL N/A Nov 19, 1999
0.5MG tablet Discontinued ORAL N/A Nov 19, 1999


Manufacturing Plant Locations
New

Novo Nordisk Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novo Nordisk Inc as present at those locations.

Country City Firm Name
United States
Plainsboro Novo Nordisk Inc.




19. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01% cream Prescription VAGINAL AB Jan 22, 2018
0.1% (0.75GM/PACKET) gel Prescription TRANSDERMAL AB Nov 14, 2023
0.1% (1GM/PACKET) gel Prescription TRANSDERMAL AB Nov 14, 2023
0.1% (1.25GM/PACKET) gel Prescription TRANSDERMAL AB Nov 14, 2023
0.1% (0.25GM/PACKET) gel Prescription TRANSDERMAL AB Nov 14, 2023
0.1% (0.5GM/PACKET) gel Prescription TRANSDERMAL AB Nov 14, 2023


Manufacturing Plant Locations
New

Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.

Country City Firm Name
Israel
Yerucham Padagis Israel Pharmaceuticals Ltd.




20. PRASCO

Prasco Llc Dba Prasco Laboratories has filed for 1 generic for Estradiol. Given below are the details of the strengths of this generic introduced by Prasco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01% cream Prescription VAGINAL AB Jul 15, 2021


Manufacturing Plant Locations
New

Prasco's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Prasco as present at those locations.

Country City Firm Name
United States
Mason Prasco LLC




21. QUAGEN

Quagen Pharmaceuticals Llc has filed for 5 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Quagen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% (0.25GM/PACKET) gel Prescription TRANSDERMAL AB Jul 12, 2024
0.1% (0.5GM/PACKET) gel Prescription TRANSDERMAL AB Jul 12, 2024
0.1% (0.75GM/PACKET) gel Prescription TRANSDERMAL AB Jul 12, 2024
0.1% (1GM/PACKET) gel Prescription TRANSDERMAL AB Jul 12, 2024
0.1% (1.25GM/PACKET) gel Prescription TRANSDERMAL AB Jul 12, 2024


Manufacturing Plant Locations
New

Quagen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Quagen as present at those locations.

Country City Firm Name
United States
West Caldwell Quagen Pharma, LLC
West Caldwell Quagen Pharmacuticals, LLC




22. SOLARIS PHARMA CORP

Solaris Pharma Corp has filed for 1 generic for Estradiol. Given below are the details of the strengths of this generic introduced by Solaris Pharma Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.06% (1.25GM/ACTIVATION) gel, metered Prescription TRANSDERMAL AB Apr 22, 2024


Manufacturing Plant Locations
New

Solaris Pharma Corp's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Solaris Pharma Corp as present at those locations.

Country City Firm Name
United States
Bridgewater Solaris Pharma Corp




23. TEVA PHARMS USA

Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MCG tablet Prescription VAGINAL AB Jul 21, 2017
0.01% cream Prescription VAGINAL AB Mar 30, 2018






24. USL PHARMA

Usl Pharma Inc has filed for 3 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Usl Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG tablet Discontinued ORAL N/A Apr 17, 2002
2MG tablet Discontinued ORAL N/A Apr 17, 2002
1MG tablet Discontinued ORAL N/A Apr 17, 2002






25. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Estradiol. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1MG/24HR film, extended release Prescription TRANSDERMAL AB2 Mar 29, 2023
0.075MG/24HR film, extended release Prescription TRANSDERMAL AB2 Mar 29, 2023
0.05MG/24HR film, extended release Prescription TRANSDERMAL AB2 Mar 29, 2023
0.0375MG/24HR film, extended release Prescription TRANSDERMAL AB2 Mar 29, 2023
0.025MG/24HR film, extended release Prescription TRANSDERMAL AB2 Mar 29, 2023
0.06MG/24HR film, extended release Prescription TRANSDERMAL AB2 Mar 29, 2023
0.014MG/24HR system Prescription TRANSDERMAL AB Apr 17, 2023